| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Pathology, Division of Cellular and Molecular Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Interstitial myofibroblasts are 
-smooth muscle actin-positive cells that play a crucial role in the accumulation of excess extracellular matrix during renal interstitial fibrogenesis. Despite their importance in the pathogenesis of renal fibrosis, relatively little is known about the regulators and the mechanism controlling the activation of renal interstitial myofibroblasts in disease conditions. Here, we show that hepatocyte growth factor (HGF) acts as a potent inhibitor of the transforming growth factor (TGF)-ß1-mediated myofibroblastic activation from normal rat renal interstitial fibroblasts (NRK-49F). Simultaneous incubation of HGF abolished TGF-ß1-induced de novo -smooth muscle actin expression, F-actin reorganization, and interstitial collagen I overproduction in a dose-dependent manner. To decipher the mechanism underlying HGF antagonizing TGF-ß1’s action, we examined the effects of HGF on TGF-ß1-mediated Smad signaling. HGF neither inhibited Smad-2/3 phosphorylation and their association with Smad-4 induced by TGF-ß1, nor significantly affected inhibitory Smad-6 and -7 expression and cellular abundance of Smad transcriptional co-repressors in NRK-49F cells. However, pretreatment with HGF markedly attenuated activated Smad-2/3 nuclear translocation and accumulation. This action of HGF was apparently dependent on HGF-mediated extracellular signal-regulated kinase-1 and -2 (Erk-1/2) phosphorylation and activation. Inhibition of Erk-1/2 activation by Mek kinase inhibitor PD98059 restored TGF-ß1-mediated Smad-2/3 nuclear accumulation and myofibroblast activation. In vivo, HGF selectively blocked Smad-2/3 nuclear accumulation in renal interstitial cells in the fibrotic kidneys induced by unilateral ureteral obstruction. Therefore, HGF suppresses TGF-ß1-mediated renal interstitial myofibroblastic activation; and this action of HGF is likely related to a mitogen-activated protein kinase-dependent blockade of Smad nuclear translocation.
This article has been cited by other articles:
 |
|
 |
|
  M. Giannopoulou, C. Dai, X. Tan, X. Wen, G. K. Michalopoulos, and Y. Liu Hepatocyte Growth Factor Exerts Its Anti-Inflammatory Action by Disrupting Nuclear Factor-{kappa}B Signaling Am. J. Pathol., July 1, 2008; 173(1): 30 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Cushing, P. D. Mariner, J.-T. Liao, E. A. Sims, and K. S. Anseth Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells FASEB J, June 1, 2008; 22(6): 1769 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hu, L. Lin, X. Tan, J. Yang, G. Bu, W. M. Mars, and Y. Liu tPA Protects Renal Interstitial Fibroblasts and Myofibroblasts from Apoptosis J. Am. Soc. Nephrol., March 1, 2008; 19(3): 503 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tan, X. Zhang, J. Yang, Y. Li, and Y. Liu Molecular Basis for the Cell Type Specific Induction of SnoN Expression by Hepatocyte Growth Factor J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2340 - 2349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tan, J. Zhang, X. Tan, X. Zhang, J. Yang, and Y. Liu Downregulation of SnoN Expression in Obstructive Nephropathy Is Mediated by an Enhanced Ubiquitin-Dependent Degradation J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2781 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Giannopoulou, S. C. Iszkula, C. Dai, X. Tan, J. Yang, G. K. Michalopoulos, and Y. Liu Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-{gamma} inhibition of TGF-beta1 action Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1234 - F1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, X. Wen, B. C. Spataro, K. Hu, C. Dai, and Y. Liu Hepatocyte Growth Factor Is a Downstream Effector that Mediates the Antifibrotic Action of Peroxisome Proliferator-Activated Receptor-{gamma} Agonists J. Am. Soc. Nephrol., January 1, 2006; 17(1): 54 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chatziantoniou and J.-C. Dussaule Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol, August 1, 2005; 289(2): F227 - F234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yang, C. Dai, and Y. Liu A Novel Mechanism by which Hepatocyte Growth Factor Blocks Tubular Epithelial to Mesenchymal Transition J. Am. Soc. Nephrol., January 1, 2005; 16(1): 68 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dai, J. Yang, S. Bastacky, J. Xia, Y. Li, and Y. Liu Intravenous Administration of Hepatocyte Growth Factor Gene Ameliorates Diabetic Nephropathy in Mice J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2637 - 2647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action Am J Physiol Renal Physiol, July 1, 2004; 287(1): F7 - F16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dai and Y. Liu Hepatocyte Growth Factor Antagonizes the Profibrotic Action of TGF-{beta}1 in Mesangial Cells by Stabilizing Smad Transcriptional Corepressor TGIF J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1402 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yang, X. Zhang, Y. Li, and Y. Liu Downregulation of Smad Transcriptional Corepressors SnoN and Ski in the Fibrotic Kidney: An Amplification Mechanism for TGF-{beta}1 Signaling J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3167 - 3177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Vet. Pathol., November 1, 2003; 40(6): 730 - 731. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
